| Literature DB >> 35330467 |
Young Suk Kwon1,2, Sang-Hwa Lee1,3, Chulho Kim1,3, Hyunjae Yu1, Jong-Hee Sohn1,3, Jae Jun Lee1,2, Dong-Kyu Kim1,4.
Abstract
The relationship between dementia and surgery remains unclear. Research to elucidate the relationship between them is scarce, and conducting epidemiological research is complicated. This study aimed to investigate the incidence and risk of dementia according to the surgery type. We performed a retrospective propensity score-matched cohort study using nationwide representative cohort sample data from the Korean National Health Insurance Service in South Korea between 2003 and 2004. Incidence rates for dementia were obtained by dividing the number of patients with dementia by person-years at risk. To identify the risk of dementia according to the type of surgery, we investigated the hazard ratio by each surgery type. The incidence rates of dementia in control, musculoskeletal, and two or more surgeries groups were 9.66, 13.47, and 13.36 cases per 1000 person-years, respectively. The risk of dementia in the musculoskeletal and two or more surgeries groups was 1.44-fold higher (95% confidence interval (95% CI), 1.22-1.70) and 1.42-fold higher (95% CI, 1.17-1.72) than that in the control group, respectively. Patients who underwent musculoskeletal surgery and two or more surgeries had a higher risk of dementia; however, there was no association with the type of anesthesia administered.Entities:
Keywords: Alzheimer’s disease; anesthesia; dementia; incidence rate; surgery type; vascular dementia
Year: 2022 PMID: 35330467 PMCID: PMC8955036 DOI: 10.3390/jpm12030468
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1Flow chart of study design. CCI—Charlson comorbidity index.
KCD code of dementia.
| Code | Disease |
| F00 | Dementia in Alzheimer’s disease |
| G30 | Alzheimer’s disease |
| F01 | Vascular dementia |
| F02 | Dementia in other diseases classified elsewhere |
| F03 | Unspecified dementia |
F stands for mental and behavioral disorders; G stands for diseases of the nervous system; KCD—Korean Standard Classification of Disease.
List of Charlson’s comorbidities and weights.
| Comorbidities | International Classification of Disease, 10th Revision Code | Original Weight | Updated Weight |
|---|---|---|---|
| Myocardial infarction | I21.x, I22.x, I25.2 | 1 | 0 |
| Congestive heart failure | I09.9, I11.0, I13.0, I13.2, I25.5, I42.0, I42.5-I42.9, I43.x, I50.x, P29.0 | 1 | 2 |
| Peripheral vascular disease | I70.x, I71.x, I73.1, I73.8, I73.9, I77.1, I79.0, I79.2, K55.1, K55.8, K55.9, Z95.8, Z95.9 | 1 | 0 |
| Cerebrovascular disease | G45.x, G46.x, H34.0, I60.x-I69.x | 1 | 0 |
| Chronic pulmonary disease | I27.8, I27.9, J40.x-J47.x, J60.x-J67.x, J68.4, J70.1, J70.3 | 1 | 1 |
| Rheumatologic disease | M05.x, M06.x, M31.5, M32.x-M34.x, M35.1, M35.3, M36.0 | 1 | 1 |
| Peptic ulcer disease | K25.x-K28.x | 1 | 0 |
| Mild liver disease | B18.x, K70.0-K70.3, K70.9, K71.3-K71.5, K71.7, K73.x, K74.x, K76.0, K76.2-K76.4, K76.8, K76.9, Z94.4 | 1 | 2 |
| Diabetes without chronic complication | E10.0, E10.1, E10.6, E10.8, E10.9, E11.0, E11.1, E11.6, E11.8, E11.9, E12.0, E12.1, E12.6, E12.8, E12.9, E13.0, E13.1, E13.6, E13.8, E13.9, E14.0, E14.1, E14.6, E14.8, E14.9 | 1 | 0 |
| Diabetes with chronic complication | E10.2-E10.5, E10.7, E11.2-E11.5, E11.7, E12.2-E12.5, E12.7, E13.2-E13.5, E13.7, E14.2-E14.5, E14.7 | 2 | 1 |
| Hemiplegia or paraplegia | G04.1, G11.4, G80.1, G80.2, G81.x, G82.x, G83.0-G83.4, G83.9 | 2 | 2 |
| Renal disease | I12.0, I13.1, N03.2-N03.7, N05.2-N05.7, N18.x, N19.x, N25.0, Z49.0-Z49.2, Z94.0, Z99.2 | 2 | 1 |
| Any malignancy including leukemia and lymphoma | C00.x-C26.x, C30.x-C34.x, C37.x-C41.x, C43.x, C45.x-C58.x, C60.x-C76.x, C81.x-C85.x, C88.x, C90.x-C97.x | 2 | 2 |
| Moderate or severe liver disease | I85.0, I85.9, I86.4, I98.2, K70.4, K71.1, K72.1, K72.9, K76.5, K76.6, K76.7 | 3 | 4 |
| Metastatic solid tumor | C77.x-C80.x | 6 | 6 |
| Acquired immune deficiency syndrome/human immunodeficiency virus | B20.x-B22.x, B24.x | 6 | 4 |
Reference: [58].
Description of time to event and censored data.
| Surgical type | The number of dementia events |
| Non-anesthesia | 615 |
| Musculoskeletal | 189 |
| Skin and soft part | 22 |
| Digestive | 107 |
| Urogenital | 29 |
| Obstetric gynecology | 16 |
| Neurosurgical | 1 |
| Circulatory | 9 |
| Others | 182 |
| 2 or more | 125 |
| Surgical type | The number of censored cases (no event) |
| Non-anesthesia | 6681 |
| Musculoskeletal | 1500 |
| Skin and soft part | 165 |
| Digestive | 1264 |
| Urogenital | 362 |
| Obstetric gynecology | 170 |
| Neurosurgical | 13 |
| Circulatory | 82 |
| Others | 1871 |
| 2 or more | 1189 |
| Surgical type | The number of termination cases |
| Non-anesthesia | 5063 |
| Musculoskeletal | 1154 |
| Skin and soft part | 131 |
| Digestive | 874 |
| Urogenital | 257 |
| Obstetric gynecology | 153 |
| Neurosurgical | 12 |
| Circulatory | 48 |
| Others | 1485 |
| 2 or more | 713 |
| Surgical type | The number of follow-up loss or drop-out cases |
| Non-anesthesia | 1618 |
| Musculoskeletal | 346 |
| Skin and soft part | 34 |
| Digestive | 390 |
| Urogenital | 105 |
| Obstetric gynecology | 17 |
| Neurosurgical | 1 |
| Circulatory | 34 |
| Others | 386 |
| 2 or more | 476 |
Characteristics of the cohort.
| Variables | Comparison | Surgery under Anesthesia | |
|---|---|---|---|
|
| 1.000 | ||
| Male | 3303 (45.3%) | 3304 (45.3%) | |
| Female | 3993 (54.7%) | 3992 (54.7%) | |
|
| 1.000 | ||
| 55–64 | 3636 (49.8%) | 3635 (49.8%) | |
| 65–74 | 2667 (36.6%) | 2668 (36.6%) | |
| ≥75 | 993 (13.6%) | 993 (13.6%) | |
|
| 1.000 | ||
| Seoul | 1574 (21.6%) | 1574 (21.6%) | |
| Second area | 1522 (20.9%) | 1522 (20.9%) | |
| Third area | 4200 (57.6%) | 4200 (57.6%) | |
|
| 1.000 | ||
| Low (0–30%) | 1489 (20.4%) | 1489 (20.4%) | |
| Middle (30–70%) | 2377 (32.6%) | 2377 (32.6%) | |
| High (70–100%) | 3430 (47.0%) | 3430 (47.0%) | |
|
| 1.000 | ||
| 0 | 3273 (44.9%) | 3273 (44.9%) | |
| 1 | 1358 (18.6%) | 1358 (18.6%) | |
| ≥2 | 2665 (36.5%) | 2665 (36.5%) |
Comparison—subjects without anesthesia; Seoul—the largest metropolitan area; second area—other metropolitan cities; third area—other areas; CCI—Charlson comorbidity index.
Figure A1Balance plot for key variables before and after matching.
Figure 2Risk of development of dementia according to surgery type.
Figure 3Cumulative hazard plot of specific disease according to surgery type: (A) Alzheimer’s disease and (B) vascular dementia.
Incidence per 1000 person-years and HR (95% CIs) of dementia during the follow-up period.
| Surgical Site | N | Case | Incidence | Unadjusted HR | Adjusted HR | |
|---|---|---|---|---|---|---|
| Comparison | 7296 | 615 | 9.66 | 1.00 (ref) | 1.00 (ref) | |
| Musculoskeletal | 1689 | 189 | 13.47 | 1.46 (1.24–1.72) * | 1.44 (1.22–1.70) * | <0.001 |
| Skin and soft part | 187 | 22 | 13.99 | 1.51 (0.99–2.31) | 1.51 (0.99–2.32) | 0.057 |
| Digestive | 1371 | 107 | 9.75 | 1.06 (0.86–1.30) | 1.03 (0.84–1.27) | 0.776 |
| Urogenital | 391 | 29 | 9.13 | 0.99 (0.68–1.44) | 0.89 (0.61–1.30) | 0.561 |
| Obstetric gynecology | 186 | 16 | 9.08 | 0.95 (0.58–1.56) | 0.89 (0.54–1.47) | 0.653 |
| Neurosurgical | 14 | 1 | 7.80 | 0.82 (0.11–5.81) | 1.42 (0.20–10.10) | 0.727 |
| Circulatory | 91 | 9 | 13.87 | 1.55 (0.80–2.99) | 1.92 (0.99–3.72) | 0.052 |
| Others | 2053 | 182 | 10.32 | 1.10 (0.94–1.30) | 1.14 (0.97–1.35) | 0.114 |
| 2 or more | 1314 | 125 | 13.36 | 1.48 (1.22–1.80) * | 1.42 (1.17–1.72) * | <0.001 |
HR—hazard ratio; CI—confidence interval. * p < 0.001.
Hazard ratios of all-cause dementia according to the sex among surgical sites.
| Sex | Male | Female | ||
| Unadjusted HR (95% CI) | Adjusted HR (95% CI) | Unadjusted HR (95% CI) | Adjusted HR (95% CI) | |
|
| ||||
| Comparison | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
| Musculoskeletal | 1.47 (1.10–1.96) ** | 1.56 (1.17–2.09) ** | 1.43 (1.17–1.74) *** | 1.38 (1.13–1.69) ** |
| Skin and soft part | 1.48 (0.70–3.14) | 1.61 (0.76–3.43) | 1.51 (0.90–2.53) | 1.46 (0.87–2.45) |
| Digestive | 1.20 (0.90–1.62) | 1.11 (0.83–1.50) | 1.02 (0.76–1.36) | 0.95 (0.71–1.28) |
| Urogenital | 1.06 (0.67–1.68) | 0.79 (0.50–1.24) | 1.26 (0.65–2.44) | 1.31 (0.68–2.54) |
| Obstetric gynecology | – | – | 0.84 (0.51–1.38) | 0.89 (0.54–1.47) |
| Neurosurgical | 1.67 (0.23–11.91) | 1.98 (0.28–14.18) | 0.00 (0-Inf) | 0.00 (0-Inf) |
| Circulatory | 2.07 (0.92–4.65) | 2.06 (0.91–4.64) | 1.16 (0.37–3.61) | 1.67 (0.54–5.22) |
| Others | 0.93 (0.67–1.29) | 0.98 (0.70–1.36) | 1.13 (0.93–1.37) | 1.21 (1.00–1.47) |
| 2 or more | 1.45 (1.05–2.00) * | 1.35 (0.97–1.86) | 1.52 (1.19–1.93) *** | 1.47 (1.16–1.87) ** |
HR—hazard ratio; CI—confidence interval. * p < 0.05, ** p < 0.010, and *** p < 0.001.
Incidence per 1000 person-years and HR (95% CI) of specific diseases (Alzheimer’s disease and vascular dementia) according to the surgical site.
| Variables | N | Case | Incidence | Unadjusted HR | Adjusted HR | |
|---|---|---|---|---|---|---|
|
| ||||||
| Comparison | 7296 | 450 | 7.01 | 1.00 (ref) | 1.00 (ref) | |
| Musculoskeletal | 1689 | 148 | 10.46 | 1.57 (1.31–1.90) ** | 1.55 (1.28–1.86) ** | <0.001 |
| Skin and soft part | 187 | 17 | 10.63 | 1.59 (0.98–2.58) | 1.59 (0.98–2.58) | 0.061 |
| Digestive | 1371 | 76 | 6.87 | 1.03 (0.81–1.32) | 1.01 (0.79–1.29) | 0.918 |
| Urogenital | 391 | 22 | 6.88 | 1.04 (0.68–1.59) | 0.95 (0.62–1.47) | 0.827 |
| Obstetric gynecology | 186 | 14 | 7.93 | 1.15 (0.67–1.95) | 1.06 (0.62–1.80) | 0.839 |
| Neurosurgical | 14 | 0 | 0 | 0.00 (0-Inf) | 0.00 (0-Inf) | 0.984 |
| Circulatory | 91 | 5 | 7.62 | 1.17 (0.49–2.83) | 1.51 (0.62–3.64) | 0.363 |
| Others | 2053 | 138 | 7.76 | 1.15 (0.95–1.39) | 1.19 (0.98–1.44) | 0.078 |
| 2 or more | 1314 | 97 | 10.27 | 1.58 (1.27–1.97) ** | 1.50 (1.21–1.88) ** | <0.001 |
|
| ||||||
| Comparison | 7296 | 122 | 1.88 | 1.00 (ref) | 1.00 (ref) | |
| Musculoskeletal | 1689 | 30 | 2.07 | 1.14 (0.76–1.70) | 1.13 (0.76–1.69) | 0.553 |
| Skin and soft part | 187 | 6 | 3.72 | 2.04 (0.90–4.62) | 2.02 (0.89–4.60) | 0.092 |
| Digestive | 1371 | 26 | 2.33 | 1.29 (0.84–1.97) | 1.25 (0.81–1.91) | 0.312 |
| Urogenital | 391 | 5 | 1.54 | 0.85 (0.35–2.09) | 0.70 (0.28–1.73) | 0.441 |
| Obstetric gynecology | 186 | 2 | 1.11 | 0.59 (0.15–2.39) | 0.62 (0.15–2.51) | 0.501 |
| Neurosurgical | 14 | 0 | 0 | 0.00 (0-Inf) | 0.00 (0-Inf) | 0.990 |
| Circulatory | 91 | 2 | 3.01 | 1.70 (0.42–6.87) | 1.91 (0.47–7.75) | 0.366 |
| Others | 2053 | 30 | 1.66 | 0.90 (0.61–1.35) | 0.94 (0.63–1.41) | 0.772 |
| 2 or more | 1314 | 27 | 2.80 | 1.57 (1.04–2.39) * | 1.49 (0.98–2.26) | 0.064 |
HR—hazard ratio; CI—confidence interval. * p < 0.05, and ** p < 0.001.
Incidence per 1000 person-years and HR (95% CI) of dementia according to anesthesia method of musculoskeletal surgery.
| Non-Matching | ||||||
|---|---|---|---|---|---|---|
| Variables | N | Case | Incidence | Unadjusted HR | Adjusted HR | |
|
| ||||||
| General anesthesia | 1004 | 108 | 12.55 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 552 | 64 | 15.06 | 1.22 (0.90–1.66) | 0.98 (0.71–1.35) | 0.884 |
|
| ||||||
| General anesthesia | 1004 | 82 | 9.45 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 552 | 53 | 12.37 | 1.44 (1.00–2.07) | 1.08 (0.75–1.54) | 0.690 |
|
| ||||||
| General anesthesia | 1004 | 19 | 2.14 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 552 | 7 | 1.59 | 0.77 (0.32–1.83) | 0.77 (0.31–1.87) | 0.557 |
|
| ||||||
|
|
|
|
|
|
|
|
|
| ||||||
| General anesthesia | 552 | 64 | 14.14 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 552 | 64 | 15.06 | 1.07 (0.76–1.52) | 1.06 (0.75–1.52) | 0.733 |
|
| ||||||
| General anesthesia | 552 | 49 | 10.74 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 552 | 53 | 12.37 | 1.16 (0.79–1.71) | 1.18 (0.79–1.75) | 0.426 |
|
| ||||||
| General anesthesia | 552 | 10 | 2.13 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 552 | 7 | 1.59 | 0.76 (0.29–1.99) | 0.79 (0.30–2.12) | 0.640 |
HR—hazard ratio; CI—confidence interval.
Incidence per 1000 person-years and HR (95% CI) of dementia according to anesthesia method of two or more surgeries.
| Non-Matching | ||||||
|---|---|---|---|---|---|---|
| Variables | N | Case | Incidence | Unadjusted HR | Adjusted HR | |
|
| ||||||
| General anesthesia | 791 | 64 | 12.29 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 158 | 23 | 20.19 | 1.64 (1.02–2.64) | 1.11 (0.67–1.84) | 0.697 |
|
| ||||||
| General anesthesia | 791 | 47 | 8.92 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 158 | 18 | 15.78 | 1.78 (1.03–3.07) | 1.29 (0.73–2.30) | 0.386 |
|
| ||||||
| General anesthesia | 791 | 17 | 3.17 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 158 | 3 | 2.54 | 0.79 (0.23–2.70) | 0.43 (0.12–1.53) | 0.192 |
|
| ||||||
|
|
|
|
|
|
|
|
|
| ||||||
| General anesthesia | 158 | 23 | 23.12 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 158 | 23 | 20.19 | 0.86 (0.48–1.53) | 0.99 (0.54–1.82) | 0.970 |
|
| ||||||
| General anesthesia | 158 | 19 | 18.72 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 158 | 18 | 15.78 | 0.83 (0.44–1.59) | 1.06 (0.54–2.08) | 0.866 |
|
| ||||||
| General anesthesia | 158 | 8 | 7.62 | 1.00 (ref) | 1.00 (ref) | |
| Neuraxial anesthesia | 158 | 3 | 2.54 | 0.33 (0.09–1.26) | 0.45 (0.11–1.78) | 0.253 |
HR—hazard ratio; CI—confidence interval.
Hazard ratios of dementia by CCI among surgery type according to surgery scale.
| CCI | 0 | 1 | ≥2 | |||
|---|---|---|---|---|---|---|
| Unadjusted HR (95% CI) | Adjusted HR (95% CI) | Unadjusted HR (95% CI) | Adjusted HR (95% CI) | Unadjusted HR (95% CI) | Adjusted HR (95% CI) | |
|
| ||||||
| Comparison | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
| Minor | 1.43 (1.03–1.98) * | 1.51 (1.09–2.09) * | 1.45 (0.92–2.30) | 1.90 (1.19–3.04) ** | 1.22 (0.69–2.15) | 1.25 (0.71–2.20) |
| Major | 1.84 (1.24–2.74) ** | 1.64 (1.10–2.45) * | 1.59 (0.91–2.77) | 1.93 (1.09–3.40) * | 1.26 (0.59–2.70) | 1.16 (0.54–2.51) |
CCI—Charlson comorbidity index; HR—hazard ratio; CI—confidence interval. * p < 0.05, and ** p < 0.010.
Incidence per 1000 person-years and HR (95% CI) of specific diseases (Alzheimer’s disease and vascular dementia) according to surgery scale.
| Variables | N | Case | Incidence | Unadjusted HR | Adjusted HR | |
|---|---|---|---|---|---|---|
|
| ||||||
| Comparison | 1689 | 105 | 6.97 | 1.00 (ref) | 1.00 (ref) | |
| Minor | 1167 | 97 | 9.75 | 1.46 (1.10–1.92) * | 1.60 (1.21–2.11) ** | <0.001 |
| Major | 522 | 51 | 12.14 | 1.83 (1.31–2.56) ** | 1.68 (1.20–2.35) * | 0.003 |
|
| ||||||
| Comparison | 1689 | 22 | 1.44 | 1.00 (ref) | 1.00 (ref) | |
| Minor | 1167 | 22 | 2.17 | 1.52 (0.84–2.75) | 1.62 (0.90–2.94) | 0.109 |
| Major | 522 | 8 | 1.85 | 1.30 (0.58–2.93) | 1.20 (0.53–2.70) | 0.661 |
HR—hazard ratio; CI—confidence interval. * p < 0.010, and ** p < 0.001.